EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhang, Huihua ^a   Chen, Xiaojia ^a   Wang, Jiakang ^b   Guang, Wenhua ^a   Han, Wei ^a   Zhang, Hang ^a   Tan, Xuan ^a   Gu, Yong ^c  

^a National Engineering Research Center of Genetic Medicine   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; KRT18 PROTEIN, HUMAN; PROTEIN BINDING; TRANSCRIPTOME;

APOPTOSIS; BINDING SITE; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; SECONDARY; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-18; LUNG NEOPLASMS; LYMPHATIC METASTASIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTOME; UP-REGULATION;

EID: 84903951875     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05416     Document Type: Article

References (38)

1. Ngiam, N., Post, M. & Kavanagh, B. P. Early growth response factor-1 in acute lung injury. AM J PHYSIOL-LUNG C 293, L1089-1091 (2007). (Pubitemid 350159393)
2. Liu, C., Rangnekar, V. M., Adamson, E. & Mercola, D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5, 3-28 (1998). (Pubitemid 128639987)
3. O'Donovan, K. J., Tourtellotte, W. G., Millbrandt, J. & Baraban, J. M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends NeurosciI 22, 167-173 (1999). (Pubitemid 29166785)
4. Gitenay, D. & Baron, V. T. Is EGR1 a potential target for prostate cancer therapy? Future Oncol 5, 993-1003 (2009).
5. Swirnoff, A. H. et al. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol Cell Biol 18, 512-524 (1998). (Pubitemid 28021062)
6. Ehrengruber, M. U. et al. Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene 258, 63-69 (2000).
7. Thiel, G. & Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193, 287-292 (2002). (Pubitemid 35265949)
8. Adamson, E. D.Mercola, D. Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumor Biol 23, 93-102 (2002). (Pubitemid 34639111)
9. Whitmarsh, A. J., Shore, P., Sharrocks, A. D. & Davis, R. J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407 (1995).
10. Silverman, E. S. & Collins, T. Pathways of Egr-1-mediated gene transcription in vascular biology. AM J Pathol 154, 665-670 (1999). (Pubitemid 29122584)
11. Adamson, E. et al. Egr1 signaling in prostate cancer. Cancer Biol Ther 2, 617-622 (2003).
12. Boone, D. N., Qi, Y., Li, Z. & Hann, S. R. Egr1 mediates p53-independent c-Mycinduced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. P Natl Acad Sci USA 108, 632-637 (2011).
13. Yu, J. et al. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J 28, 21-33 (2009).
14. Baron, V., Adamson, E.D., Calogero, A., Ragona, G.Mercola, D.The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 13, 115-124 (2006). (Pubitemid 43113412)
15. Ferraro, B., Bepler, G., Sharma, S., Cantor, A. Haura, E. B. EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer. J Clin Oncol 23, 1921-1926 (2005). (Pubitemid 46211370)
16. Yechiel Levkovitz, J. M. B. A Dominant Negative Inhibitor of the Egr Family of Transcription Regulatory Factors Suppresses Cerebellar Granule Cell Apoptosis by Blocking c-Jun Activation. J Neurosci 21, 5893-5910 (2001).
17. Gregg, J. & Fraizer, G. Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells. Genes Cancer 2, 900-909 (2011).
18. Weng, Y. R., Cui, Y. & Fang, J. Y. Biological functions of cytokeratin 18 in cancer. Mol Cancer Res 10, 485-493 (2012).
19. Samaneh Saberi, et al A Potential Association between Helicobacter pylori CagA EPIYA and Multimerization Motifs with Cytokeratin 18 Cleavage Rate during Early Apoptosis. Helicobacter 17, 350-357 (2012).
20. Huang, R. P. et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72, 102-109 (1997).
21. Liu, C., Y, F., Mercola, D.Adamson, E. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 55, 5054-5062 (1995).
22. Potikha, T., Kassem, S., Haber, E. P., Ariel, I. & Glaser, B. p57Kip2 (cdkn1c): sequence, splice variants and unique temporal and spatial expression pattern in the rat pancreas. Lab Invest 85, 364-375 (2005). (Pubitemid 40333153)
23. Matsuoka, S. et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Gene Dev 9, 650-662 (1995).
24. Xu, X. Y. et al. Clinical implications of p57 KIP2 expression in breast cancer. Asian Pac J Cancer 13, 5033-5036 (2012).
25. Jin, L., Williamson, A., Banerjee, S., Philipp, I. & Rape, M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133, 653-665 (2008). (Pubitemid 351636306)
26. Sakaue, M., Adachi, H. & Jetten, A. M. Post-transcriptional regulation ofMyD118 and GADD45 in human lung carcinoma cells during 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid-induced apoptosis. Mol Pharmacol 55, 668-676 (1999). (Pubitemid 29165431)
27. Takekawa, M. & Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521-530 (1998). (Pubitemid 28533308)
28. Greenhalf, W., Lee, J. & Chaudhuri, B. A selection system for human apoptosis inhibitors using yeast. Yeast 15, 1307-1321 (1999). (Pubitemid 29445804)
29. Okazawa, S. et al. Inactivation of DNA-dependent protein kinase promotes heatinduced apoptosis independently of heat-shock protein induction in human cancer cell lines. Plos one 8, e58325 (2013).
30. Monsalve, F. A. et al. Inhibition of human topoisomerase I and activation of caspase-3 by aza-angucyclinones and arylaminopyrimido[4, 5-c]isoquinoline-7, 10-quinones. Int J Mol Med 30, 151-156 (2012).
31. Fortier, A. M., Asselin, E. & Cadrin, M. Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J Biol Chem 288, 11555-11571 (2013).
32. Li, Q. X., Ke, N., Sundaram, R. & Wong-Staal, F. NR4A1, 2, 3-an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 21, 533-540 (2006).
33. Ai, L. et al. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis 29, 510-518 (2008). (Pubitemid 351404866)
34. Oshima, R. G. Apoptosis and keratin intermediate filaments. Cell Death Differ 9, 486-492 (2002).
35. Caulin, C., Salvesen, G. S. & Oshima, R. G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138, 1379-1394 (1997). (Pubitemid 27415063)
36. Yilmaz, Y. Systematic review: caspase-cleaved fragments of cytokeratin 18-the promises and challenges of a biomarker for chronic liver disease. Aliment Pharm Therap 30, 1103-1109 (2009).
37. Huang da, W. et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35, W169-175 (2007).
38. Lv, H. et al. Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs. Mol Biosyst 6, 2056-2067 (2010).